Aggravated MRSA pneumonia secondary to influenza A virus infection is derived from decreased expression of IL‐1β

Autor: Benquan Wu, Jingjing Liang, Xiaohan Shi, Jinmei Luo, Jun-Hui Ba, Yunfeng Shi, Jian-ning Chen
Rok vydání: 2020
Předmět:
Zdroj: Journal of Medical Virology
ISSN: 1096-9071
0146-6615
DOI: 10.1002/jmv.26329
Popis: Secondary methicillin‐resistant Staphylococcus aureus (MRSA) infection is a cause of severe pneumonia with high mortality during influenza A virus (IAV) pandemics. Alveolar macrophages (AMs) mount cellular defenses against IAV and MRSA infection, which occurs via the nucleotide‐binding domain‐like receptor protein 3 (NLRP3) inflammasome. However, the activity and function of the NLRP3 inflammasome in MRSA pneumonia secondary to IAV infection remain unclear. To clarify this, we studied MRSA infection secondary to IAV both in vitro and in mouse model. The expression of the NLRP3 inflammasome was evaluated by quantitative reverse transcription polymerase chain reaction, immunofluorescence, Western blot, and enzyme‐linked immunosorbent assay. The lung pathology and the rate of weight change were observed. We found that IAV infection for 1 week activated NLRP3 inflammasome. The enhanced expression of NLRP3, caspase‐1, and cleaved caspase‐1 was associated with MRSA infection secondary to IAV, but the expression of interleukin (IL)‐1β decreased in superinfection with MRSA both in vitro and in vivo. The aggravated inflammatory pathology in MRSA pneumonia secondary to IAV infection was associated with decreased expression of IL‐1β. And increased weight loss in MRSA pneumonia secondary to IAV infection was related to decreased concentration of IL‐1β in serum. It infers that superinfection with MRSA reduces expression of IL‐1β someway, and decreased expression of IL‐1β impairs the host immunity and leads to aggravated pneumonia. These results contributed to our understanding of the detailed activity of the NLRP3 inflammasome, IL‐1β, and their relationship with aggravation of MRSA pneumonia secondary to IAV infection. Immunotherapy targeting the IL‐1β signaling pathway could be possible therapeutic strategy for secondary MRSA pneumonia.
Highlights MRSA pneumonia secondary to influenza A virus infection causes severe outcome.NLRP3 inflammasome plays a role in the pathogenesis of MRSA pneumonia secondary to IAV infection.The aggravated inflammatory pathology in MRSA pneumonia secondary to IAV infection was associated with decreased expression of IL‐1β.Immunotherapy targeting the NLRP3 inflammasome and IL‐1β signaling pathway could be possible therapeutic strategy for secondary MRSA pneumonia.
Databáze: OpenAIRE
Externí odkaz: